Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
SPAN's Cash to Debt is ranked higher than
93% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SPAN: No Debt )
SPAN' s 10-Year Cash to Debt Range
Min: 0.22   Max: No Debt
Current: No Debt

Equity to Asset 0.86
SPAN's Equity to Asset is ranked higher than
83% of the 450 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SPAN: 0.86 )
SPAN' s 10-Year Equity to Asset Range
Min: 0.58   Max: 0.86
Current: 0.86

0.58
0.86
Interest Coverage 277.77
SPAN's Interest Coverage is ranked higher than
66% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. SPAN: 277.77 )
SPAN' s 10-Year Interest Coverage Range
Min: 69.61   Max: 9999.99
Current: 277.77

69.61
9999.99
F-Score: 6
Z-Score: 10.00
M-Score: -2.89
WACC vs ROIC
1.78%
10.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 6.46
SPAN's Operating margin (%) is ranked higher than
78% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 5.50 vs. SPAN: 6.46 )
SPAN' s 10-Year Operating margin (%) Range
Min: -0.43   Max: 13.42
Current: 6.46

-0.43
13.42
Net-margin (%) 4.64
SPAN's Net-margin (%) is ranked higher than
77% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. SPAN: 4.64 )
SPAN' s 10-Year Net-margin (%) Range
Min: 2.02   Max: 8.61
Current: 4.64

2.02
8.61
ROE (%) 8.51
SPAN's ROE (%) is ranked higher than
82% of the 449 Companies
in the Global Medical Devices industry.

( Industry Median: 5.02 vs. SPAN: 8.51 )
SPAN' s 10-Year ROE (%) Range
Min: 3.18   Max: 31.29
Current: 8.51

3.18
31.29
ROA (%) 7.24
SPAN's ROA (%) is ranked higher than
88% of the 481 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. SPAN: 7.24 )
SPAN' s 10-Year ROA (%) Range
Min: 2.4   Max: 20.31
Current: 7.24

2.4
20.31
ROC (Joel Greenblatt) (%) 24.30
SPAN's ROC (Joel Greenblatt) (%) is ranked higher than
86% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 6.67 vs. SPAN: 24.30 )
SPAN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1.07   Max: 56.97
Current: 24.3

-1.07
56.97
Revenue Growth (3Y)(%) 0.30
SPAN's Revenue Growth (3Y)(%) is ranked higher than
65% of the 344 Companies
in the Global Medical Devices industry.

( Industry Median: 4.90 vs. SPAN: 0.30 )
SPAN' s 10-Year Revenue Growth (3Y)(%) Range
Min: -4.5   Max: 16.8
Current: 0.3

-4.5
16.8
EBITDA Growth (3Y)(%) -9.40
SPAN's EBITDA Growth (3Y)(%) is ranked higher than
67% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. SPAN: -9.40 )
SPAN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -15   Max: 46.6
Current: -9.4

-15
46.6
EPS Growth (3Y)(%) -12.50
SPAN's EPS Growth (3Y)(%) is ranked higher than
69% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. SPAN: -12.50 )
SPAN' s 10-Year EPS Growth (3Y)(%) Range
Min: -17.8   Max: 133.9
Current: -12.5

-17.8
133.9
» SPAN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

SPAN Guru Trades in Q1 2014

Jim Simons 50,600 sh (+4.33%)
» More
Q2 2014

SPAN Guru Trades in Q2 2014

Jim Simons 52,300 sh (+3.36%)
» More
Q3 2014

SPAN Guru Trades in Q3 2014

Jim Simons 58,100 sh (+11.09%)
» More
Q4 2014

SPAN Guru Trades in Q4 2014

Jim Simons 58,600 sh (+0.86%)
» More
» Details

Insider Trades

Latest Guru Trades with SPAN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.80
SPAN's P/E(ttm) is ranked higher than
93% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 120.60 vs. SPAN: 21.80 )
SPAN' s 10-Year P/E(ttm) Range
Min: 4.96   Max: 22.75
Current: 21.8

4.96
22.75
Forward P/E 11.31
SPAN's Forward P/E is ranked higher than
97% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 11.31 )
N/A
PE(NRI) 21.40
SPAN's PE(NRI) is ranked higher than
92% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 94.20 vs. SPAN: 21.40 )
SPAN' s 10-Year PE(NRI) Range
Min: 4.94   Max: 22.65
Current: 21.4

4.94
22.65
P/B 1.80
SPAN's P/B is ranked higher than
85% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 4.16 vs. SPAN: 1.80 )
SPAN' s 10-Year P/B Range
Min: 1.12   Max: 5.55
Current: 1.8

1.12
5.55
P/S 1.00
SPAN's P/S is ranked higher than
90% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 3.75 vs. SPAN: 1.00 )
SPAN' s 10-Year P/S Range
Min: 0.4   Max: 1.42
Current: 1

0.4
1.42
PFCF 19.20
SPAN's PFCF is ranked higher than
95% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 19.20 )
SPAN' s 10-Year PFCF Range
Min: 5.24   Max: 218.83
Current: 19.2

5.24
218.83
POCF 15.13
SPAN's POCF is ranked higher than
91% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 74.13 vs. SPAN: 15.13 )
SPAN' s 10-Year POCF Range
Min: 4.56   Max: 25.29
Current: 15.13

4.56
25.29
EV-to-EBIT 12.56
SPAN's EV-to-EBIT is ranked higher than
95% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 68.02 vs. SPAN: 12.56 )
SPAN' s 10-Year EV-to-EBIT Range
Min: 3.1   Max: 17.4
Current: 12.56

3.1
17.4
Shiller P/E 12.20
SPAN's Shiller P/E is ranked higher than
98% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 12.20 )
SPAN' s 10-Year Shiller P/E Range
Min: 7.34   Max: 30.95
Current: 12.2

7.34
30.95
Current Ratio 4.67
SPAN's Current Ratio is ranked higher than
73% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 2.58 vs. SPAN: 4.67 )
SPAN' s 10-Year Current Ratio Range
Min: 2.35   Max: 4.67
Current: 4.67

2.35
4.67
Quick Ratio 3.04
SPAN's Quick Ratio is ranked higher than
72% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. SPAN: 3.04 )
SPAN' s 10-Year Quick Ratio Range
Min: 1.62   Max: 3.78
Current: 3.04

1.62
3.78
Days Inventory 64.99
SPAN's Days Inventory is ranked higher than
92% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 157.38 vs. SPAN: 64.99 )
SPAN' s 10-Year Days Inventory Range
Min: 25.76   Max: 70.54
Current: 64.99

25.76
70.54
Days Sales Outstanding 38.24
SPAN's Days Sales Outstanding is ranked higher than
91% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 78.80 vs. SPAN: 38.24 )
SPAN' s 10-Year Days Sales Outstanding Range
Min: 38.24   Max: 83.89
Current: 38.24

38.24
83.89

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.11
SPAN's Dividend Yield is ranked higher than
86% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.43 vs. SPAN: 3.11 )
SPAN' s 10-Year Dividend Yield Range
Min: 0.89   Max: 4.38
Current: 3.11

0.89
4.38
Dividend Payout 0.60
SPAN's Dividend Payout is ranked higher than
82% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 0.60 )
SPAN' s 10-Year Dividend Payout Range
Min: 0.17   Max: 0.66
Current: 0.6

0.17
0.66
Dividend growth (3y) 10.70
SPAN's Dividend growth (3y) is ranked higher than
83% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. SPAN: 10.70 )
SPAN' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 27.4
Current: 10.7

0
27.4
Yield on cost (5-Year) 5.04
SPAN's Yield on cost (5-Year) is ranked higher than
92% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.54 vs. SPAN: 5.04 )
SPAN' s 10-Year Yield on cost (5-Year) Range
Min: 1.4   Max: 6.9
Current: 5.04

1.4
6.9
Share Buyback Rate -1.80
SPAN's Share Buyback Rate is ranked higher than
76% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -1.40 vs. SPAN: -1.80 )
SPAN' s 10-Year Share Buyback Rate Range
Min: 7.9   Max: -2.6
Current: -1.8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 32.80
SPAN's Price/Net Cash is ranked higher than
62% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 32.80 )
SPAN' s 10-Year Price/Net Cash Range
Min: 5.63   Max: 49.11
Current: 32.8

5.63
49.11
Price/Net Current Asset Value 5.70
SPAN's Price/Net Current Asset Value is ranked higher than
91% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 5.70 )
SPAN' s 10-Year Price/Net Current Asset Value Range
Min: 1.95   Max: 22.16
Current: 5.7

1.95
22.16
Price/Tangible Book 2.40
SPAN's Price/Tangible Book is ranked higher than
86% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 6.96 vs. SPAN: 2.40 )
SPAN' s 10-Year Price/Tangible Book Range
Min: 0.68   Max: 5.95
Current: 2.4

0.68
5.95
Price/DCF (Projected) 0.80
SPAN's Price/DCF (Projected) is ranked higher than
98% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 0.80 )
SPAN' s 10-Year Price/DCF (Projected) Range
Min: 0.35   Max: 1.77
Current: 0.8

0.35
1.77
Price/Median PS Value 1.40
SPAN's Price/Median PS Value is ranked higher than
72% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 1.36 vs. SPAN: 1.40 )
SPAN' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 1.41
Current: 1.4

0.49
1.41
Price/Graham Number 1.50
SPAN's Price/Graham Number is ranked higher than
92% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SPAN: 1.50 )
SPAN' s 10-Year Price/Graham Number Range
Min: 0.58   Max: 1.76
Current: 1.5

0.58
1.76
Earnings Yield (Greenblatt) 7.90
SPAN's Earnings Yield (Greenblatt) is ranked higher than
95% of the 476 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. SPAN: 7.90 )
SPAN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.8   Max: 32
Current: 7.9

5.8
32
Forward Rate of Return (Yacktman) 4.37
SPAN's Forward Rate of Return (Yacktman) is ranked higher than
75% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 5.08 vs. SPAN: 4.37 )
SPAN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.2   Max: 44.9
Current: 4.37

3.2
44.9

Analyst Estimate

Sep15
EPS($) 1.92
EPS without NRI($) 1.92

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Span-America Medical Systems, Inc., is incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.
» More Articles for SPAN

Headlines

Articles On GuruFocus.com
7 Stocks Paying More Cash with Higher Dividends Aug 12 2013 
Span-America Medical Systems: 92nd Consecutive Dividend and Debt Free Dec 04 2012 
Heinz Increases Dividend 7.3%, And These 5 Other Stocks Raised Dividends May 28 2012 
Guru Stocks Raising Dividends: CATO, POR, VIA, SPAN, HPQ May 28 2012 
cheap stable, could Aug 09 2011 
Pass all 3 apart fro Aug 06 2011 
11 Cheapest Healthcare Dividend Stocks to Consider Aug 02 2011 
Span-America (SPAN) – 2010 Review + Future Outlook Jan 20 2011 
SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q) Feb 16 2010 
SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q) Feb 10 2009 

More From Other Websites
Nasdaq stocks posting largest volume decreases Mar 04 2015
SPAN AMERICA MEDICAL SYSTEMS INC Financials Feb 24 2015
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security... Feb 23 2015
10-Q for Span-America Medical Systems, Inc. Feb 19 2015
Span-America Declares Quarterly Cash Dividend Feb 19 2015
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report Feb 17 2015
Reports Improved First Quarter 2015 Results Feb 09 2015
To Release First Quarter 2015 Results on February 3, 2015 Feb 09 2015
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 03 2015
Span-America Reports Improved First Quarter 2015 Results Feb 03 2015
Span-America Medical Systems To Release First Quarter 2015 Results On February 3, 2015 Jan 28 2015
10-K for Span-America Medical Systems, Inc. Dec 25 2014
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report Dec 23 2014
To Nominate Thomas J. Sullivan to Board of Directors Dec 09 2014
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Nov 18 2014
Span-America to Nominate Thomas J. Sullivan to Board of Directors Nov 18 2014
Reports Fourth Quarter and Fiscal Year 2014 Results Nov 17 2014
Declares Special Cash Dividend of $1.00 Per Share and Regular Quarterly Dividend of $0.15 Per Share Nov 17 2014
SPAN AMERICA MEDICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... Nov 14 2014
Span-America Declares Special Cash Dividend of $1.00 Per Share and Regular Quarterly Dividend of... Nov 14 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK